Neuralink, Elon Musk's brain implant venture, is reaching out to major U.S. neurosurgery centers to potentially begin testing its devices on humans, according to a Reuters report. Before that can happen though, the U.S. government needs to grant the company approval, which is far from certain. In 2022, the U.S. Food and Drug Administration rejected its application to proceed with human trials due to safety concerns. Neuralink has been working to address those concerns ever since.
The Food and Drug Administration is kicking off a two-day meeting to consider whether to let people get birth control pills without a prescription, with a decision expected by the summer.
Dr. Deena Gupta-Adimoolam, a primary care specialist, joined Cheddar News to talk about how people can prepare themselves for emergency hospital visits.
